(Total Views: 569)
Posted On: 08/13/2021 8:01:15 AM
Post# of 148898
I'm surprised that nobody's talking about this:
CytoDyn Receives FDA Guidance for its HIV BLA Dose Justification Report
Company Believes All Issues Are Addressable and it Will Be Able to Continue BLA Resubmission
CMC and Non-Clinical Sections Will Be Fully Resubmitted as Early as September 2021
https://www.cytodyn.com/newsroom/press-releas...v-bla-dose
CytoDyn Receives FDA Guidance for its HIV BLA Dose Justification Report
Company Believes All Issues Are Addressable and it Will Be Able to Continue BLA Resubmission
CMC and Non-Clinical Sections Will Be Fully Resubmitted as Early as September 2021
https://www.cytodyn.com/newsroom/press-releas...v-bla-dose
(2)
(0)
My comments are just my opinions and should NOT be taken as investment advice.
Scroll down for more posts ▼
